Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$57.7M
+8.8% from 2023
Prescriptions
6,395
$9,022.87 per claim
Patients
908
738 prescribers
Total spending, 2024
$57.7M
$63,439.61 per patient
Medicare prescription drug plans paid $57.7M for Somatuline Depot in 2024, for 6,395 prescriptions and refills to 908 patients (up 8.8% from 2023). The average cost per claim was $9,022.87.
New York had the highest Medicare cost for Somatuline Depot in 2024: $11.7M for 1,292 claims, followed by California ($5.4M).
Boris Bagdasarian, hematology-oncology in Glendale, CA, had the highest Medicare cost for Somatuline Depot in 2024: 70 claims costing $903K.
Somatuline Depot is made by Ipsen S.a. (IPN.PA), listed in the Medicare spending data as Ipsen Biopharma.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Boris Bagdasarian Glendale, CA | Hematology-Oncology | 70 | Under 11 | $903K |
| Noshir A Dacosta Smithtown, NY | Medical Oncology | 93 | 11 | $836K |
| Jin S Lee |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 583 | 5,133 | 666 | $49.7M |
| 2023 | 595 | 5,439 | 674 | $53.0M |
| 2024 | 738 | 6,395 | 908 | $57.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 71 |
| Under 11 |
| $704K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 67 | Under 11 | $625K |
| Aasim S Sehbai Anniston, AL | Medical Oncology | 63 | Under 11 | $575K |
| Noman Rafique Massillon, OH | Hematology-Oncology | 69 | Under 11 | $575K |
| Jerry J George Port Jefferson Station, NY | Hematology-Oncology | 59 | Under 11 | $548K |
| Eric H Liu Denver, CO | Surgical Oncology | 47 | Under 11 | $500K |
| Susannah P Friemel Davenport, IA | Internal Medicine | 56 | Under 11 | $486K |
| Nagaprasad Nagajothi Massillon, OH | Hematology-Oncology | 55 | Under 11 | $486K |
| Peter J Snyder Philadelphia, PA | Internal Medicine | 48 | Under 11 | $445K |
| Samir C Patel Newburgh, NY | Hematology-Oncology | 49 | Under 11 | $432K |
| Harsha Vyas Dublin, GA | Internal Medicine | 44 | Under 11 | $420K |
| Amory V Novoselac New York, NY | Hematology-Oncology | 43 | Under 11 | $390K |
| Gurmohan Syali E Setauket, NY | Hematology-Oncology | 44 | Under 11 | $390K |
| David T Chu Port Jefferson Station, NY | Hematology-Oncology | 40 | Under 11 | $366K |
| Louis J Avvento Southampton, NY | Medical Oncology | 39 | Under 11 | $353K |
| Deepali Sharma Riverhead, NY | Internal Medicine | 38 | Under 11 | $351K |
| Jean G Bustamante New York, NY | Hematology-Oncology | 37 | Under 11 | $329K |
| Alexander I Zuhoski Riverhead, NY | Medical Oncology | 36 | Under 11 | $323K |
| Thomas R Blom Princeton, NJ | Hematology-Oncology | 32 | Under 11 | $302K |
| John J Graham Canfield, OH | Hematology-Oncology | 32 | Under 11 | $300K |
| Jyotika K Fernandes Charleston, SC | Endocrinology | 39 | Under 11 | $299K |
| Regina L Jablonski Port Jefferson Station, NY | Hematology-Oncology | 32 | Under 11 | $292K |
| Adriana Guigova Port Jefferson Station, NY | Hematology-Oncology | 31 | Under 11 | $289K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Ipsen Biopharma IPN.PA | 6,398 | $57.7M |